International Symposium on Infectious Diseases, Vaccines and Immune Responses
ISIDVIR
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest innovations in vaccine technology, including novel adjuvants and delivery systems. Emphasis will be placed on the rapid development of vaccines in response to emerging infectious diseases.
SDG 3
SDG 4
This session will delve into the immune responses elicited by various pathogens and how these responses influence disease outcomes. Discussions will include the role of innate and adaptive immunity in controlling infections.
SDG 3
SDG 4
This track will focus on the complex interactions between pathogens and their hosts, highlighting mechanisms of pathogenesis and immune evasion. Research presented will aim to uncover potential therapeutic targets for infectious diseases.
SDG 3
SDG 9
This session will address the clinical aspects of immunology in the context of infectious diseases, including diagnostic advancements and treatment strategies. Participants will discuss case studies that illustrate the impact of immunological research on patient care.
SDG 3
SDG 4
This track will examine the rise of emerging infectious diseases and their implications for global health security. Presentations will cover surveillance, outbreak response, and strategies for prevention and control.
SDG 3
SDG 17
This session will review the latest findings on vaccine efficacy and safety across different populations and pathogens. Discussions will include the challenges of conducting clinical trials and post-marketing surveillance.
SDG 3
SDG 4
This track will investigate the genetic factors that influence individual immune responses to infections and vaccinations. Research presented will highlight the implications of immunogenetics for personalized medicine.
SDG 3
SDG 9
This session will explore the potential of immunotherapeutic approaches in the treatment of infectious diseases. Topics will include monoclonal antibodies, therapeutic vaccines, and adoptive cell transfer.
SDG 3
SDG 4
This track will focus on the social and psychological factors contributing to vaccine hesitancy. Presentations will discuss strategies to improve public trust and vaccine uptake.
SDG 3
SDG 16
This session will explore the influence of the microbiome on susceptibility to infectious diseases and the immune response. Research will highlight potential therapeutic interventions targeting the microbiome.
SDG 3
SDG 15
This track will discuss international efforts and policies aimed at controlling infectious diseases. Topics will include vaccination programs, public health initiatives, and collaborative research efforts across borders.
SDG 3
SDG 17